0001213900-23-058916.txt : 20230721 0001213900-23-058916.hdr.sgml : 20230721 20230721171517 ACCESSION NUMBER: 0001213900-23-058916 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230720 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20230721 DATE AS OF CHANGE: 20230721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tenon Medical, Inc. CENTRAL INDEX KEY: 0001560293 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455574718 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41364 FILM NUMBER: 231103276 BUSINESS ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: (408) 649-5760 MAIL ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 8-K 1 ea182108-8k_tenonmed.htm CURRENT REPORT
0001560293 false 0001560293 2023-07-20 2023-07-20 0001560293 TNON:CommonStockParValue0.001PerShareMember 2023-07-20 2023-07-20 0001560293 TNON:WarrantsEachWithRightToPurchaseOneShareOfCommonStockMember 2023-07-20 2023-07-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): 

July 20, 2023

 

TENON MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41364   45-5574718
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

104 Cooper Court

Los Gatos, CA

  95032
(Address of principal executive offices)   (Zip Code)

 

(408) 649-5760

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   TNON   The Nasdaq Stock Market LLC
Warrants, each with a right to purchase one share of Common Stock   TNONW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

  

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On July 20, 2023, Tenon Medical, Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) therein stating that for the 30 consecutive business day period between June 6, 2023 through July 19, 2023, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until January 16, 2024 (the “Compliance Period”), to regain compliance with the Bid Price Rule.

 

To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of 10 consecutive trading days, unless extended by Nasdaq under Nasdaq Rule 5810(c)(3)(H), prior to January 16, 2024.

 

If the Company does not regain compliance with the Bid Price Rule by January 16, 2024, the Company may be eligible for an additional 180-day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Rule, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary.

 

If the Company cannot regain compliance during the Compliance Period or any subsequently granted compliance period, the common stock of the Company will be subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq hearings panel.

 

The notice from Nasdaq has no immediate effect on the listing of the Company’s common stock and its common stock will continue to be listed on The Nasdaq Capital Market under the symbol “TNON.” The Company is currently evaluating its options for regaining compliance. There can be no assurance that the Company will regain compliance with the Bid Price Rule or maintain compliance with any of the other Nasdaq continued listing requirements.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 21, 2023

TENON MEDICAL, INC.
     
  By: /s/ Steven M. Foster
  Name: Steven M. Foster
  Title: Chief Executive Officer and President

 

2

 

EX-101.SCH 2 tnon-20230720.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 tnon-20230720_def.xml XBRL DEFINITION FILE EX-101.LAB 4 tnon-20230720_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants, each with a right to purchase one share of Common Stock Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 tnon-20230720_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 20, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 20, 2023
Entity File Number 001-41364
Entity Registrant Name TENON MEDICAL, INC.
Entity Central Index Key 0001560293
Entity Tax Identification Number 45-5574718
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 104 Cooper Court
Entity Address, City or Town Los Gatos
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95032
City Area Code 408
Local Phone Number 649-5760
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.001 per share  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol TNON
Security Exchange Name NASDAQ
Warrants, each with a right to purchase one share of Common Stock  
Title of 12(b) Security Warrants, each with a right to purchase one share of Common Stock
Trading Symbol TNONW
Security Exchange Name NASDAQ
XML 7 ea182108-8k_tenonmed_htm.xml IDEA: XBRL DOCUMENT 0001560293 2023-07-20 2023-07-20 0001560293 TNON:CommonStockParValue0.001PerShareMember 2023-07-20 2023-07-20 0001560293 TNON:WarrantsEachWithRightToPurchaseOneShareOfCommonStockMember 2023-07-20 2023-07-20 iso4217:USD shares iso4217:USD shares 0001560293 false 8-K 2023-07-20 TENON MEDICAL, INC. DE 001-41364 45-5574718 104 Cooper Court Los Gatos CA 95032 408 649-5760 false false false false Common Stock, par value $0.001 per share TNON NASDAQ Warrants, each with a right to purchase one share of Common Stock TNONW NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://tenonmed.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea182108-8k_tenonmed.htm tnon-20230720.xsd tnon-20230720_def.xml tnon-20230720_lab.xml tnon-20230720_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea182108-8k_tenonmed.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "tnon-20230720_def.xml" ] }, "inline": { "local": [ "ea182108-8k_tenonmed.htm" ] }, "labelLink": { "local": [ "tnon-20230720_lab.xml" ] }, "presentationLink": { "local": [ "tnon-20230720_pre.xml" ] }, "schema": { "local": [ "tnon-20230720.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 2, "memberStandard": 0, "nsprefix": "TNON", "nsuri": "http://tenonmed.com/20230720", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea182108-8k_tenonmed.htm", "contextRef": "From2023-07-20to2023-07-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://tenonmed.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea182108-8k_tenonmed.htm", "contextRef": "From2023-07-20to2023-07-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "TNON_CommonStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "localname": "CommonStockParValue0.001PerShareMember", "nsuri": "http://tenonmed.com/20230720", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "domainItemType" }, "TNON_WarrantsEachWithRightToPurchaseOneShareOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants, each with a right to purchase one share of Common Stock" } } }, "localname": "WarrantsEachWithRightToPurchaseOneShareOfCommonStockMember", "nsuri": "http://tenonmed.com/20230720", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://tenonmed.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001213900-23-058916-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-058916-xbrl.zip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end